Doximity (DOCS)
(Delayed Data from NYSE)
$27.64 USD
-0.09 (-0.33%)
Updated Jun 3, 2024 04:00 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DOCS 27.64 -0.09(-0.33%)
Will DOCS be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for DOCS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DOCS
Doximity (DOCS) Upgraded to Buy: Here's What You Should Know
Company News for May 20, 2024
DOCS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Doximity (DOCS) Q4 Earnings and Revenues Surpass Estimates
Ahead of Doximity (DOCS) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Organon (OGN) Tops Q1 Earnings and Revenue Estimates
Other News for DOCS
Dr. Martens Names New Company Secretary
Dr. Martens CFO Invests in Company’s Future
LONDON BROKER RATINGS: RBC raises Centrica; Citigroup says buy BHP
Dr. Martens Confirms Share Capital and Voting Rights
Doximity to Present at the William Blair 44th Annual Growth Stock Conference